You are here: Industry Insights > neuroscience

News List

Fondazione Prada Presents "Human Brains," A Multidisciplinary Project Dedicated To Brain Studies prnasia
October 16, 2020
"Human Brains" is a multidisciplinary project dedicated to brain studies taking place from November 2020 to November 2022.
Novartis snaps up AveXis in $8.7bn deal pharmatimes
July 17, 2018
Novartis is buying US gene therapy group AveXis in a deal valued at $8.7 billion.
Pfizer unveils $600m investment in venture capital arm pharmatimes
July 06, 2018
Pfizer is planning to invest $600 million in biotechnology and other emerging growth companies through its venture investment group.
Pfizer puts neuroscience at heart of new $600M VC fund fiercebiotech
June 11, 2018
Pfizer has committed $600 million to its VC fund. The Big Pharma is setting aside 25% of the money for investments in neuroscience startups, giving it a way to continue participating in the field despite its retreat from in-house R&D.
Pfizer Confirms Neuroscience Cuts, Shelves Another 4 Early-Stage Projects biospace
January 31, 2018
Pharma giant Pfizer started January with news it was abandoning research and development of new neuroscience programs that included potential therapies for Alzheimer’s and Parkinson’s.
UCLA neuroscientists use weak electrical signal to stimulate human brain and improve memory biospectrumasia
October 30, 2017
People with epilepsy who received low-current electrical pulses showed a significant improvement in their ability to recognize specific faces and ignore similar ones.
McGill teams up with Japan’s NIPS for neuroscience research biospectrumasia
October 19, 2017
The objective of this MoU is to further strengthen the world-class neuroscience research being done at both institutes.
Lilly-backed Cavion poaches Teva executive as R&D head fiercebiotech
August 16, 2017
Cavion got off a $26.1 million series A financing this year with Lilly Ventures, Novartis Venture Fund and Enso Ventures.
GSK to close it neuroscience R&D center in China biospectrumasia
August 14, 2017
The lab led the firm’s research efforts in neurological diseases including Parkinson’s, multiple sclerosis, and Alzheimer’s
Shire mulls over separation of neuroscience unit pharmatimes
August 07, 2017
Shire is considering cleaving its neuroscience division into a separate, publicly-listed entity in a move that would afford the firm a sharper focus on rare diseases